We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genzyme Makes Progress on Warning Letter, FDA Re-Inspecting Plant
Genzyme Makes Progress on Warning Letter, FDA Re-Inspecting Plant
May 21, 2009
Genzyme has completed all actions needed to respond to the FDA’s recent warning letter that cited good manufacturing practice (GMP) deficiencies at the company’s Allston, Mass., production facility.